These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 2455135

  • 1. Clinical use of calcium antagonists in hypertension: update 1986.
    Lund-Johansen P.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S29-35. PubMed ID: 2455135
    [Abstract] [Full Text] [Related]

  • 2. Calcium antagonists--assessment of side effects.
    Thulin T.
    Scand J Prim Health Care Suppl; 1990; 1():81-4. PubMed ID: 2100370
    [Abstract] [Full Text] [Related]

  • 3. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B, Brilla C, Kruse T, Noll B, Bethge C.
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [Abstract] [Full Text] [Related]

  • 4. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis].
    Brandt D.
    Wien Med Wochenschr; 1983 Mar 31; 133(6):131-5. PubMed ID: 6134398
    [Abstract] [Full Text] [Related]

  • 5. Influence of diuretics, calcium antagonists, and alpha-blockers on insulin sensitivity and glucose tolerance in hypertensive patients.
    Ramsay LE, Yeo WW, Jackson PR.
    J Cardiovasc Pharmacol; 1992 Mar 31; 20 Suppl 11():S49-53; discussion S53-4. PubMed ID: 1284144
    [Abstract] [Full Text] [Related]

  • 6. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S, Bakir SE.
    Drugs; 2000 Mar 31; 59 Spec No 2():25-37. PubMed ID: 11002856
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Update on calcium-channel blocking agents.
    Talbert RL, Bussey HI.
    Clin Pharm; 1983 Mar 31; 2(5):403-16. PubMed ID: 6354566
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR.
    Z Kardiol; 1984 Mar 31; 73 Suppl 2():95-9. PubMed ID: 6152093
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.
    Omvik P, Lund-Johansen P.
    Ann Clin Res; 1988 Mar 31; 20 Suppl 48():23-30. PubMed ID: 3250315
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W, Brandt D, Vrecko K, Härringer M.
    Circ Res; 1983 Feb 31; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative studies of calcium-channel blockers and beta-blockers in essential hypertension: clinical implications.
    Massie BM, Tubau JF, Szlachcic J.
    Circulation; 1987 Jun 31; 75(6 Pt 2):V163-9. PubMed ID: 2882873
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV, Nedostup AV.
    Ter Arkh; 2006 Jun 31; 78(8):30-8. PubMed ID: 17078214
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.
    Opie LH.
    Cardiovasc Drugs Ther; 1988 Mar 31; 1(6):625-56. PubMed ID: 3154329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.